These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9128999)

  • 1. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
    Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL
    Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine.
    Nishiyama K; Yao T; Yonemasu H; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2002; 9(2):293-300. PubMed ID: 11836595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
    Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
    Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
    Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
    N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
    Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
    N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Findings of genetic changes in small intestinal carcinomas].
    Hirai A; Hibi K; Nakamura H; Fujikake Y; Matsui T; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():332-6. PubMed ID: 9263525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas.
    Gonzalez-Cadavid NF; Zhou D; Battifora H; Bar-Eli M; Cline MJ
    Oncogene; 1989 Sep; 4(9):1137-40. PubMed ID: 2674856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.
    Cuatrecasas M; Erill N; Musulen E; Costa I; Matias-Guiu X; Prat J
    Cancer; 1998 Mar; 82(6):1088-95. PubMed ID: 9506354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
    Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
    Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of ras oncogene activation in human lung cancer.
    Rodenhuis S; Slebos RJ
    Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent K-ras mutations in small bowel adenocarcinomas.
    Sutter T; Arber N; Moss SF; Findling RI; Neugut AI; Weinstein IB; Holt PR
    Dig Dis Sci; 1996 Jan; 41(1):115-8. PubMed ID: 8565742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.